October 08, 2020 Mapping the transatlantic divide for biotech flotations A look at how drug developers fare after floating in Europe suggests why many tread a path to the US and a Nasdaq listing.
November 27, 2019 Investors see no end in sight to the misery of hayfever Twin setbacks for grass pollen allergy projects in development by Asit Biotech and Allergy Therapeutics expose an existential crisis.
